6-acetylaminocaproic acid has been researched along with Reperfusion Injury in 1 studies
6-acetylaminocaproic acid: wound-healing agent component of plasmutan
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadj Abdallah, N | 1 |
| Baulies, A | 1 |
| Bouhlel, A | 1 |
| Bejaoui, M | 1 |
| Zaouali, MA | 1 |
| Ben Mimouna, S | 1 |
| Messaoudi, I | 1 |
| Fernandez-Checa, JC | 1 |
| García Ruiz, C | 1 |
| Ben Abdennebi, H | 1 |
1 other study available for 6-acetylaminocaproic acid and Reperfusion Injury
| Article | Year |
|---|---|
The effect of zinc acexamate on oxidative stress, inflammation and mitochondria induced apoptosis in rat model of renal warm ischemia.
Topics: Aminocaproates; Animals; Antioxidants; Apoptosis; Cytokines; Disease Models, Animal; Dose-Response R | 2018 |